Psychiatric disorders often coexist with internal medical conditions, posing significant challenges to diagnosis, treatment, and overall patient outcomes. This study examines the bidirectional relationship between these conditions, emphasizing their impact on morbidity, treatment adherence, and quality of life. Through a comprehensive review of the peer-reviewed literature, we explore the physiological, neuroinflammatory, and psychosocial mechanisms that underpin these interactions. Key psychiatric disorders, including depression, anxiety, cognitive impairments, and psychosis, are identified as critical contributors to diagnostic complexity and therapeutic hurdles. Our findings underscore the importance of integrated, multidisciplinary care models, advocating for early detection, routine mental health screening, and personalized treatment strategies. Challenges such as overlapping symptoms, diagnostic ambiguities, and potential drug interactions are critically analyzed, with practical, evidence-based recommendations proposed for clinical practice. Despite advancements, significant research gaps persist, particularly the lack of longitudinal studies and the limited application of precision medicine tailored to this population. Future directions focus on enhancing diagnostic tools, developing innovative therapeutic approaches, and integrating mental health services into routine care. This study highlights the critical need for holistic, patient-centered approaches to manage comorbid psychiatric and internal medical conditions, offering actionable insights to improve outcomes and bridge existing gaps in research and practice.

The utilization of evolutive models and algorithms for predicting the evolution of hepatic steatosis holds immense potential benefits. These computational approaches enable the analysis of complex datasets, capturing temporal dynamics and providing personalized prognostic insights. By optimizing intervention planning and identifying critical transition points, they promise to revolutionize our approach to understanding and managing hepatic steatosis progression, ultimately leading to enhanced patient care and outcomes in clinical settings. This paradigm shift towards a more dynamic, personalized, and comprehensive approach to hepatic steatosis progression signifies a significant advancement in healthcare. The application of evolutive models and algorithms allows for a nuanced characterization of disease trajectories, facilitating tailored interventions and optimizing clinical decision-making. Furthermore, these computational tools offer a framework for integrating diverse data sources, creating a more holistic understanding of hepatic steatosis progression. In summary, the potential benefits encompass the ability to analyze complex datasets, capture temporal dynamics, provide personalized prognostic insights, optimize intervention planning, identify critical transition points, and integrate diverse data sources. The application of evolutive models and algorithms has the potential to revolutionize our understanding and management of hepatic steatosis, ultimately leading to improved patient outcomes in clinical settings.

Background: Interfacility neonatal transport is essential for regionalized perinatal care, yet its effects on systemic immune responses remain poorly characterized. This study evaluated longitudinal changes in hematologic and inflammatory biomarkers during neonatal transport and investigated the influence of transport modality on these responses. Methods: In this prospective observational study, 161 neonates undergoing air or ground transport to Level III/IV neonatal intensive care units were evaluated at three time points: before transport (T0), immediately after transport (T1), and 12 hours after admission (T2). Physiological stability parameters, complete blood count variables, and inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and mean corpuscular volume-to-lymphocyte ratio (MCVL), were analyzed using repeated-measures and mixed-effects models adjusted for transport duration, sedation, and physiological stability. Results: Physiological stability was maintained throughout transport, with no significant changes in heart rate, oxygen saturation, or body temperature. In contrast, significant longitudinal changes were observed in leukocyte populations and inflammatory indices. Total leukocyte and neutrophil counts decreased over time, whereas lymphocyte counts increased. Mixed-effects analyses identified significant effects of time, transport modality, and Time × Transport interaction for WBC, neutrophils, lymphocytes, NLR, SII, and SIRI. These associations remained significant after adjustment for clinical and physiological confounders. MCVL also demonstrated significant effects of time, transport modality, and their interaction, emerging as a potential novel marker of transport-related immune adaptation. Conclusions: Neonatal transport is associated with significant hematologic and immune adaptations despite preserved physiological stability. Air and ground transport induce distinct patterns of leukocyte redistribution and inflammatory responses. MCVL may represent a promising biomarker of transport-related immune adaptation and warrants further investigation in neonatal transport medicine.